Heron Bay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Heron Bay Capital Management's BMY Position: Q1 2026 in Review
Heron Bay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 19,379 shares — an estimated $1.05M sold.
Heron Bay Capital Management first reported a position in BMY in Q2 2024 and held it in 7 quarters. The position peaked at $2.29M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Heron Bay Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Heron Bay Capital Management sold 19,379 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.05M.
- Heron Bay Capital Management first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 7 quarters.
- Heron Bay Capital Management's Bristol-Myers Squibb position peaked at $2.29M in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Heron Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.